Fair Value Disclosures (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value Assumptions Used |
The following assumptions were used in calculations of the Black-Scholes model for the three months ended March 31, 2016 and 2015:
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Embedded Derivative Liabilities Fair Value |
The following table presents the embedded derivative, the Companys only financial assets measured and recorded at fair value on the Companys Consolidated Balance Sheets on a recurring basis and their level within the fair value hierarchy during the three months ended March 31, 2016:
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Financial Instruments at Fair Value |
The following table reconciles, for the period ended March 31, 2016, the beginning and ending balances for financial instruments that are recognized at fair value in the consolidated financial statements:
|
|||||||||||||||||||||||||||||||||||||||||||||